Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Alpha-1D adrenergic receptor | ||
Ligand | BDBM50211321 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_444278 (CHEMBL894518) | ||
Ki | 5.5±n/a nM | ||
Citation | Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS). Bioorg Med Chem Lett17:3292-7 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Alpha-1D adrenergic receptor | |||
Name: | Alpha-1D adrenergic receptor | ||
Synonyms: | ADA1D_HUMAN | ADRA1A | ADRA1D | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1D-adrenoceptor | Alpha 1D-adrenoreceptor | Alpha adrenergic receptor (1a and 1d) | Alpha-1D adrenoceptor | Alpha-adrenergic receptor 1a | adrenergic Alpha1D | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 60485.82 | ||
Organism: | Homo sapiens (Human) | ||
Description: | adrenergic Alpha1D ADRA1D HUMAN::P25100 | ||
Residue: | 572 | ||
Sequence: |
| ||
BDBM50211321 | |||
n/a | |||
Name | BDBM50211321 | ||
Synonyms: | CHEMBL391016 | N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperazin-1-yl)cyclohexyl)pyridine-3-sulfonamide | ||
Type | Small organic molecule | ||
Emp. Form. | C24H34N4O3S | ||
Mol. Mass. | 458.617 | ||
SMILES | CC(C)Oc1ccccc1N1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1cccnc1 |wU:16.17,wD:19.24,(17.84,-39.62,;17.05,-40.94,;15.51,-40.92,;17.8,-42.28,;17.02,-43.61,;15.48,-43.59,;14.69,-44.92,;15.45,-46.26,;16.99,-46.27,;17.77,-44.95,;19.3,-44.97,;20.06,-46.31,;21.6,-46.33,;22.38,-45.01,;21.63,-43.67,;20.09,-43.65,;23.92,-45.03,;24.7,-43.7,;26.24,-43.73,;27,-45.07,;26.2,-46.39,;24.67,-46.37,;28.55,-45.11,;29.33,-43.78,;27.99,-43,;30.65,-44.54,;30.08,-42.44,;29.31,-41.12,;30.06,-39.78,;31.61,-39.76,;32.39,-41.09,;31.63,-42.43,)| | ||
Structure |